JC virus type 2B is found more frequently in brain tissue of progressive multifocal leukoencephalopathy patients than in urine from controls

Journal of Human Virology

Volumn 1, Issue 3, 1998, Pages 200-206

  Agostini, Hansjürgen T ^a,d   Ryschkewitsch, Caroline F ^a   Singer, Elyse J ^b   Baumhefner, Robert W ^b   Stoner, Gerald L ^a,c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Human polyomavirus JC type 2B; Progressive multifocal leukoencephalopathy

Indexed keywords

ADULT; ARTICLE; BRAIN; COHORT ANALYSIS; FEMALE; GENETICS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; JC VIRUS; LEUKOENCEPHALOPATHY; MALE; SERODIAGNOSIS; UNITED STATES; URINE; VIROLOGY;

ADULT; BRAIN; CALIFORNIA; COHORT STUDIES; FEMALE; GENOTYPE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MARYLAND; PENNSYLVANIA; URINE;

EID: 0032009637     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Walker DL. Progressive multifocal leukoencephalopathy. In: Vinken PJ, Bruyn GW, Klawans HL, Koetsier JC, eds. Handbook of clinical neurology: demyelinating diseases, vol. 47. Amsterdam: Elsevier, 1985:503-524.
2. Major EO, Amemiya K, Tornatore CS, et al. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy: the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992;5:49-73.
3. Yogo Y, Iida T, Taguchi F, et al. Typing of human polyomavirus JC virus on the basis of restriction fragment length polymorphisms. J Clin Microbiol 1991;29:2130-2138.
4. Agostini HT, Ryschkewitsch CF, Stoner GL. Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. J Clin Microbiol 1996;34: 159-164.
5. Agostini HT, Brubaker GR, Shao J, et al. BK virus and a new type of JC virus excreted by HIV-1 positive patients in rural Tanzania. Arch Virol 1995;140:1919-1934.
6. Guo J, Kitamura T, Ebihara H, et al. Geographical distribution of the human polyomavirus JC virus type A and B and isolation of a new type from Ghana. J Gen Virol 1996;77:919-927.
7. Sugimoto C, Kitamura T, Guo J, et al. Typing of urinary JC virus DNA offers a novel means of tracing human migrations. Proc Natl Acad Sci U S A 1997;94:9191-9196.
8. Agostini HT, Yanagihara R, Davis V, et al. Asian genotypes of JC virus in Native Americans and in a Pacific Island population: markers of viral evolution and human migration. Proc Natl Acad Sci U S A 1997;94:14542-14546.
9. Berger JR, Concha M. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J Neurovirol 1995;1:5-18.
10. Chimelli L, Rosemberg S, Hahn MD, et al. Pathology of the central nervous system in patients infected with the human immunodeficiency virus (HIV): a report of 252 autopsy cases from Brazil. Neuropathol Appl Neurobiol 1992;18:478-488.
11. Kuchelmeister K, Gullotta F, Bergman M, et al. Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS): a neuropathological study of 21 cases. Pathol Res Pract 1993;189: 163-173.
12. Lang W, Miklossy J, Deruaz JP, et al. Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol (Berl) 1989;77:379-390.
13. Agostini HT, Ryschkewitsch CF, Brubaker GR, et al. Five complete genomes of JC virus type 3 from Africans and African Americans. Arch Virol 1997;142:637-655.
14. Agostini HT, Ryschkewitsch CF, Mory R, et al. JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PML. J Infect Dis 1997;176:1-8.
15. Loeber G, Dörries K. DNA rearrangements in organspecific variants of polyomavirus JC strain GS. J Virol 1988;62:1730-1735.
16. Ault GS, Stoner GL. Human polyomavirus JC promoter/ enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure. J Gen Virol 1993;74:1499-1507.
17. Agostini HT, Ryschkewitsch CF, Singer EJ, Stoner GL. JC virus regulatory region rearrangements and genotypes in progressive multifocal leukoencephalopathy: two independent aspects of virus variation. J Gen Virol 1997;78: 659-664.
18. Yogo Y, Kitamura T, Sugimoto C, et al. Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J Virol 1990;64:3139-3143.
19. Flaegstad T, Sundsfjord A, Arthur RR, et al. Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction. Virology 1991;180:553-560.
20. Frisque RJ, Bream GL, Cannella MT. Human polyomavirus JC virus genome. J Virol 1984;51:458-469.
21. Frisque RJ, White FA, III. The molecular biology of JC virus, causative agent of progressive multifocal leukoencephalopathy. In: Roos RP, ed. Neurovirology-pathogenesis of viral CNS infections. Totowa, NJ: Humana Press, 1992:25-158.
22. Trowbridge PW, Frisque RJ. Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. J Neurovirol 1995;1:195-206.
23. Ault GS, Stoner GL. Two major types of JC virus defined in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences. J Gen Virol 1992;73:2669-2678.
24. Agostini HT, Ryschkewitsch CF, Singer EJ, Stoner GL. Coinfection with two JC virus genotypes in brain, cerebrospinal fluid or urinary tract detected by direct cycle sequencing of PCR products. J Neurovirol 1996;2:259-267.
25. Stoner GL, Agostini HT, Ryschkewitsch CF, Komoly S. JC virus excreted by multiple sclerosis patients and paired controls from Hungary. Multiple Sclerosis 1998, in press.
26. Stoner GL, Agostini HT, Ryschkewitsch CF, et al. Two cases of progressive multifocal leukoencephalopathy (PML) due to JC virus: detection of JCV type 3 in a Gambian AIDS patient. J Med Microbiol 1998, in press.
27. Stoner GL, Ryschkewitsch CF. Capsid protein VP1 deletions in JC virus from two AIDS patients with progressive multifocal leukoencephalopathy. J Neurovirol 1995;1: 189-194.
28. Stoner GL, Agostini HT, Ryschkewitsch CF, et al. Characterization of JC virus DNA amplified from urine of chronic progressive multiple sclerosis patients. Multiple Sclerosis 1996;1:193-199.
29. Matsuda M, Jona M, Yasui K, Nagashima K. Genetic characterization of JC virus Tokyo-1 strain, a variant oncogenic in rodents. Virus Res 1987;7:159-l68.
30. Raj GV, Khalili K. Transcriptional regulation - lessons from the human neurotropic polyomavirus, JCV. Virology 1995;213:283-291.
31. Daniel AM, Swenson JJ, Mayreddy RPR, et al. Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology 1996;216:90-101.
32. Sock E, Renner K, Feist D, et al. Functional comparison of PML-type and archetype strains of JC virus. J Virol 1996; 70:1512-1520.
33. Ault GS. Activity of JC virus archetype and PML-type regulatory regions in glial cells. J Gen Virol 1997;78:163-169.
34. Loeber G, Stenger JE, Ray S, et al. The zinc finger region of simian virus 40 large T antigen is needed for hexamer assembly and origin melting. J Virol 1991;65:3167-3174.
35. Swenson JJ, Trowbridge PW, Frisque RJ. Replication activity of JC virus large T antigen phosphorylation and zinc finger domain mutants. J Neurovirol 1996;2:78-86.
36. Ressetar HG, Walker DL, Webster HD, et al. Immunolabeling of JC virus large T antigen in neonatal hamster brain before tumor formation. Lab Invest 1990;62:287-296.
37. Ressetar HG, Webster Hd, Stoner GL. Brain vascular endothelial cells express JC virus large tumor antigen in immunocompetent and cyclophosphamide-treated hamsters. Proc Natl Acad Sci U S A 1992;89:8170-8174.
38. Ressetar HG, Webster Hd, Stoner GL. Persistence of neurotropic JC virus DNA in hamster tissues six months after intracerebral inoculation. J Neurovir 1997;3:66-70.